Table 5.
Sleeve gastrectomy | Roux-en-Y gastric bypass | Beta estimate | p-value | |
---|---|---|---|---|
n = 965 | n = 3899 | |||
Delta mean ± SD | Delta mean ± SD | |||
Physical functioning | 31.46 ± 24.24 | 33.61 ± 23.50 | 2.758 | 0.008* |
Social functioning | 14.85 ± 27.48 | 14.20 ± 27.84 | − 0.821 | 0.509 |
Physical role limitations | 28.28 ± 44.38 | 28.57 ± 45.73 | − 1.352 | 0.505 |
Emotional role limitations | 6.99 ± 38.94 | 5.56 ± 40.55 | − 2.650 | 0.141 |
Mental health | 7.65 ± 18.32 | 7.59 ± 18.23 | 0.483 | 0.544 |
Vitality | 14.31 ± 21.64 | 16.32 ± 22.82 | 0.919 | 0.361 |
Pain | 17.77 ± 27.17 | 19.85 ± 28.42 | 1.148 | 0.360 |
General health perception | 19.76 ± 17.20 | 22.70 ± 17.28 | 2.607 | < 0.001* |
Health change | 54.22 ± 31.02 | 55.91 ± 29.34 | − 0.072 | 0.957 |
Postoperative delta scale scores of sleeve gastrectomy and Roux-en-Y gastric bypass, measured with RAND-36. Beta’s were estimated using linear regression and adjusted for T2DM, hypertension, dyslipidaemia and musculoskeletal pain. Compared with a multivariate logistic regression analysis
SD standard deviation, T2DM type 2 diabetes mellitus
*Statistically significant results and clinically relevant difference measured